The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Karyopharm Therapeutics
Molecular predictors of response to selinexor in advanced unresectable de-differentiated liposarcoma (DDLS).
 
Christopher James Walker
Employment - Karyopharm Therapeutics
 
Hua Chang
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Travel, Accommodations, Expenses - Karyopharm Therapeutics
 
Jianjun Liu
Employment - Karyopharm Therapeutics
 
Bruno Vincenzi
Honoraria - Abbott; Novartis; PharmaMar
Consulting or Advisory Role - Abbott; Eisai; Lilly; Novartis; PharmaMar
Research Funding - Lilly; Novartis; PharmaMar
Expert Testimony - Abbott
 
Andrea Napolitano
No Relationships to Disclose
 
Bruno Bolognese
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics; Roche
 
Jatin J. Shah
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Michael G. Kauffman
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Sharon Shacham
No Relationships to Disclose
 
Yosef Landesman
Employment - Karyopharm Therapeutics